参考文献/References:
［1］HONG Ying, LI Shu-qin, HU Ya-li, et alSurvey of human papillomavirus types and their vertical transmission in pregnant women ［J］. BMC Infectious Diseases, 2013, 13(13): 109.
［2］魏振玲，黄华．妊娠期孕妇人乳头状瘤病毒感染的分型与母婴垂直传播的相关性研究 ［J］．中华医院感染学杂志，2014，24（1）：12-14．
［3］周蓓蓓，张丽娜，范燕燕，等．孕期人乳头瘤病毒感染类型与母婴垂直传播的前瞻性研究 ［J］．现代妇产科进展，2012，21（3）：208-210, 214．
［4］LIU P, XU L, SUN Y, et al. The prevalence and risk of human papillomavirus infection in pregnant women ［J］. Epidemiology and Infection, 2014, 142(8): 1567-1578.
［5］FIFE K H, KATZ B P, ROUSH J, et al. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy ［J］. American Journal of Obstetrics and Gynecology, 1996, 174(5): 1487-1493.
［6］WORDA C, HUBER A, HUDELIST G, et al. Prevalence of cervical and intrauterine human papillomavirus infection in the third trimester in asymptomatic women ［J］. Journal of the Society for Gynecologic Investigation, 2005, 12(6): 440-444.
［7］MITTAL R, PATER A, PATER M M. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions ［J］. Journal of Virology, 1993, 67(9): 5656-5659.
［8］MAILATH-POKORNY M, SCHWAMEIS R, GRIMM C, et al. Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature ［J］. BMC Pregnancy and Childbirth, 2016, 16(1): 74.
［9］GOMEZ L M, MA Y, HO C, et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery ［J］. Human Reproduction (Oxford, England), 2008, 23(3): 709-715.
［10］BOULENOUAR S, WEYN C, VAN NOPPEN M, et al. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells ［J］. Carcinogenesis, 2010, 31(3): 473-480.
［11］AMBHL L M, BAANDRUP U, DYBKR K, et al. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery ［J］. Infectious Diseases in Obstetrics and Gynecology, 2016(9): 3086036.
［12］PERINO A, GIOVANNELLI L, SCHILLACI R, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes ［J］. Fertility and Sterility, 2011, 95(5): 1845-1848.
［13］SOUHO T, BENLEMLIH M, BENNANI B. Human papillomavirus infection and fertility alteration: a systematic review ［J］. PLOS One, 2015, 10(5): e0126936.
［14］SUBRAMANIAM A, LEES B F, BECKER D A, et al. Evaluation of human papillomavirus as a risk factor for preterm birth or pregnancy-related hypertension ［J］.Obstetrics and Gynecology, 2016, 127 (2): 233-240.
［15］DA SILVA C S, ADAD S J, HAZARABEDIAN DE SOUZA M A, et al. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection ［J］. Gynecologic and Obstetric Investigation, 2004, 58(4): 189-193.
［16］LUKIC A, CANZIO C, PATELLA A, et al. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum ［J］. Anticancer Research, 2007, 26(6C): 4843-4849.
［17］CHO G, MIN K J, HONG H R, et al. High-risk human papillomavirus infection is associated with premature rupture of membranes ［J］. BMC Pregnancy and Childbirth, 2013, 13(9): 173.
［18］PARK H, LEE S W, LEE I H, et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery ［J］. Virology Journal, 2012, 119(1): 80.
［19］HAHN H S, KEE M K, KIM H J, et al. Distribution of maternal and infant human papillomavirus: risk factors associated with vertical transmission ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013, 169(2): 202-206.
［20］WORKOWSKI K A, BERMAN S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010 ［J］. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports / Centers for Disease Control, 2010, 59(12): 1-110.
［21］JACH R, GALAROWICZ B, HURAS H, et al. Vertical transmission of HPV in pregnancy. A prospective clinical study of HPV-positive pregnant women ［J］. Ginekologia Polska, 2014, 85(9): 672-676.
［22］郑晓霞，王谢桐，于珊．妊娠期人乳头瘤病毒感染对母儿影响的探讨 ［J］．实用妇产科杂志，2011，27（3）：223-226．
［23］DERKAY C S, WIATRAK B. Recurrent respiratory papillomatosis: a review ［J］. The Laryngoscope, 2008, 118(7): 1236-1247.
［24］CHATZISTAMATIOU K, SOTIRIADIS A, AGORASTOS T. Effect of mode of delivery on vertical human papillomavirus transmission - A meta-analysis ［J］. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 2016, 36(1): 10-14.
［25］MEDEIROS L R, ETHUR A B, HILGERT J B, et al. Vertical transmission of the human papillomavirus: a systematic quantitative review ［J］. Cadernos de Saude Publica, 2005, 21(4): 1006-1015.
［26］MONEY D M, ROY M. Canadian consensus guidelines on human papillomavirus ［J］. JOGC, 2007, 29(8): 1-53.
［27］VICHNIN M, BONANNI P, KLEIN N P, et al. An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015 ［J］. The Pediatric Infectious Disease Journal, 2015, 34(9): 983-991.
［28］BARIL L, ROSILLON D, WILLAME C, et al. Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom ［J］. Vaccine, 2015, 33(48): 6884-6891.
［29］BONDE U, JOERGENSEN J S, LAMONT R F, et al. Is HPV vaccination in pregnancy safe ［J］. Human Vaccines & Immunotherapeutics, 2016, 12(8): 1960-1964.
相似文献/References:
[1]侯兴华,臧玉芹,张艳,等.甲胎蛋白及增殖细胞核抗原在自然流产中的表达及意义[J].中国计划生育和妇产科,2010,(03):0.
HOU Xing-hua,ZANG Yu-qin,ZHANG Yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[2]帅翰林,罗新.射频消融技术在治疗宫颈病变和宫颈人乳头瘤病毒感染中的作用[J].中国计划生育和妇产科,2013,(01):0.
SHUAI Han-lin,LUO Xin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[3]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[4]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[5]吴晓菁,谈军,李优云,等.广州市白云区流动人口育龄妇女HPV感染及宫颈病变的流行病学调查[J].中国计划生育和妇产科,2013,(03):0.
WU Xiao - jing,TAN Jun,LI You - yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[6]代鸣,邹志梅,黄江平,等.九江地区9328例宫颈液基细胞学检查结果分析[J].中国计划生育和妇产科,2014,(01):0.
DAI Ming,ZOU Zhi-mei,HUANG Jiang-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[7]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[8]朱木华,林彩菊,叶淑英,等.广东省惠州地区流动人口育龄妇女人乳头瘤病毒感染及宫颈病变的流行病学调查[J].中国计划生育和妇产科,2014,(06):0.
ZHU Mu-hua,LIN CAI-ju,YE Shu-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[9]贾艳艳,陈志龙,史惠蓉,等.人乳头瘤病毒L1蛋白在宫颈病变中的表达及其意义[J].中国计划生育和妇产科,2014,(06):0.
JIA Yan-yan,CHEN Zhi-long,SHI Hui-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[10]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.